From Molecules to Medicine
Development of a New Drug

- Health at Bayer
-
Pharmaceuticals
- Treatments & Therapies
- Innovation & Technologies
- Cell and Gene Therapy
- Sustainability
- Transparency
- News & Stories
- Clinical Trials Explorer
- Transparency Policy
- Personal Health
- Report a Side Effect
- Medical Counterfeits
The benefits and risks of drugs are evaluated, confirmed, and double-checked
Drug development is a very complex job, which is strictly regulated. Before a new medicine hits the pharmacy shelves, scientists and physicians spend ten to twelve years comprehensively investigating the drug candidate, first in the lab and then in healthy volunteers and finally in thousands of patients who volunteer to participate in clinical studies. All the data – roughly 500,000 pages – are then submitted to the health authorities. Only when the experts at the regulatory authorities have carefully reviewed all the information and approved the drug, is it available for you, the patient.
Want to witness the journey in time lapse in an entertaining way?
Further Links